AMN107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMN107, covering 2020-12-08 to 2020-12-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL [Phase 1, Phase 2]